BCAS1 抗体 (AA 542-584) (Cy5)
-
- 抗原 See all BCAS1 抗体
- BCAS1 (Breast Carcinoma Amplified Sequence 1 (BCAS1))
-
抗原表位
- AA 542-584
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This BCAS1 antibody is conjugated to Cy5
-
应用范围
- Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- 预测反应
- Human,Mouse,Rat
- 纯化方法
- Purified by Protein A.
- 免疫原
- KLH conjugated synthetic peptide derived from human BCAS1
- 亚型
- IgG
- Top Product
- Discover our top product BCAS1 Primary Antibody
-
anti-Breast Carcinoma Amplified Sequence 1 (BCAS1) (AA 542-584) antibody
BCAS1 适用: 人 WB, ELISA, IF (cc), IF (p), IHC (p), IHC (fro), ICC 宿主: 兔 Polyclonal unconjugated
anti-Breast Carcinoma Amplified Sequence 1 (BCAS1) (AA 1-80) antibodyBCAS1 适用: 人 WB, ELISA, IHC (p) 宿主: 小鼠 Monoclonal 1B5 unconjugated
anti-Breast Carcinoma Amplified Sequence 1 (BCAS1) (AA 1-81) antibodyBCAS1 适用: 人 WB, ELISA, IHC (p), IHC 宿主: 小鼠 Monoclonal 1B5 unconjugated
anti-Breast Carcinoma Amplified Sequence 1 (BCAS1) (C-Term) antibodyBCAS1 适用: 人 WB, IHC (p), EIA 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1 μg/μL
- 缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 储存条件
- -20 °C
- 储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- 有效期
- 12 months
-
- 抗原
- BCAS1 (Breast Carcinoma Amplified Sequence 1 (BCAS1))
- 别名
- BCAS1/NABC1 (BCAS1 产品)
- 别名
- AIBC1 antibody, NABC1 antibody, 2210416M21Rik antibody, 9030223A09Rik antibody, AI841227 antibody, Band83 antibody, Pmes-2 antibody, BCAS1 antibody, MGC152145 antibody, breast carcinoma amplified sequence 1 antibody, BCAS1 antibody, Bcas1 antibody
- 背景
-
Synonyms: AIBC 1, AIBC1, Amplied and overexpressed in breast cancer, BCAS 1, BCAS1, BCAS1_HUMAN, Breast carcinoma amplied sequence 1, Breast carcinoma-amplied sequence 1, Novel amplied in breast cancer 1.
Background: NaBC1 is a protein found amplified in most breast carcinoma forms. It is expressed primarily as a cytoplasmic, detergent-stable homodimer that has a tendency to interact with DYNLL1 (PIN) and DYNLL2. Breast tumor lines that exhibit 20q13.2 gene amplification express much higher levels of the protein as compared to the levels found in other breast cancer lines that do not overexpress the NaBC1 mRNA. However, this upregulation does not affect growth rate or anchoring abilities of a cell, indicating the oncogenic properties of NaBC1 differ from that of other oncogenes.
-
